Sabeluzole

Sabeluzole

File:Sabeluzole.svg
Clinical data
ATC code	none
Legal status
Legal status	In general: unscheduled
Identifiers
IUPAC name 1-[4-[1,3-benzothiazol-2-yl(methyl)amino]piperidin-1-yl]-3-(4-fluorophenoxy)propan-2-ol
CAS Number	104383-17-7
PubChem CID	59823
ChemSpider	53964
UNII	A998504XY4
E number	{{#property:P628}}
CompTox Dashboard (EPA)	{{#property:P3117}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22H26FN3O2S
Molar mass	415.53 g·mol−1
3D model (JSmol)	Interactive image
SMILES CN(C1CCN(CC1)CC(COC2=CC=C(C=C2)F)O)C3=NC4=CC=CC=C4S3
InChI InChI=1S/C22H26FN3O2S/c1-25(22-24-20-4-2-3-5-21(20)29-22)17-10-12-26(13-11-17)14-18(27)15-28-19-8-6-16(23)7-9-19/h2-9,17-18,27H,10-15H2,1H3 Key:IGMKTIJBFUMVIN-UHFFFAOYSA-N
(verify)

Sabeluzole (R-58,735) is a nootropic and neuroprotective drug which was originally developed for the treatment of Alzheimer's disease, and has subsequently been researched for other applications such as sleep apnoea. It acts primarily as an NMDA antagonist, but other mechanisms of action may also be important.

See also

• Memantine